BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25944036)

  • 1. Words of Wisdom. Re: Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
    Ehdaie B
    Eur Urol; 2015 Jun; 67(6):1188-9. PubMed ID: 25944036
    [No Abstract]   [Full Text] [Related]  

  • 2. Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
    Kim SP; Gross CP; Nguyen PL; Smaldone MC; Shah ND; Karnes RJ; Thompson RH; Han LC; Yu JB; Trinh QD; Ziegenfuss JY; Sun M; Tilburt JC
    Med Care; 2014 Jul; 52(7):579-85. PubMed ID: 24926704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and policy perspectives on the adoption of active surveillance for low-risk prostate cancer.
    Frendl DM; Sokoloff MH
    Med Care; 2014 Jul; 52(7):576-8. PubMed ID: 24926703
    [No Abstract]   [Full Text] [Related]  

  • 4. Perceptions of Barriers Towards Active Surveillance for Low-Risk Prostate Cancer: Results From a National Survey of Radiation Oncologists and Urologists.
    Kim SP; Gross CP; Shah ND; Tilburt JC; Konety B; Williams SB; Weight CJ; Yu JB; Kumar AMS; Meropol NJ
    Ann Surg Oncol; 2019 Feb; 26(2):660-668. PubMed ID: 30311161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions of radiation oncologists and urologists on sources and type of evidence to inform prostate cancer treatment decisions.
    Han LC; Delpe S; Shah ND; Ziegenfuss JY; Tilburt JC; Karnes RJ; Nguyen PL; Gross CP; Yu JB; Trinh QD; Sun M; Ranasinghe WK; Kim SP
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):277-83. PubMed ID: 24685153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active surveillance of prostate cancer: a questionnaire survey of urologists, clinical oncologists and urology nurse specialists across three cancer networks in the United Kingdom.
    Philippou Y; Raja H; Gnanapragasam VJ
    BMC Urol; 2015 Jun; 15():52. PubMed ID: 26070313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations of Active Surveillance for Intermediate-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
    Kim SP; Shah ND; Meropol NJ; Tilburt JC; Nguyen PL; Yu JB; Abouassaly R; Kim A; Gross CP
    Eur Urol Oncol; 2019 Mar; 2(2):189-195. PubMed ID: 31017095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy choices of German urologists and radio-oncologists if personally diagnosed with localized prostate cancer].
    Gillitzer R; Hampel C; Thomas C; Schmidt F; Melchior SW; Pahernik S; Schmidberger H; Thüroff JW
    Urologe A; 2009 Apr; 48(4):399-407. PubMed ID: 19352607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.
    Taneja SS
    J Urol; 2015 Jan; 193(1):128-9. PubMed ID: 25523659
    [No Abstract]   [Full Text] [Related]  

  • 10. Shared decision making and use of decision AIDS for localized prostate cancer : perceptions from radiation oncologists and urologists.
    Wang EH; Gross CP; Tilburt JC; Yu JB; Nguyen PL; Smaldone MC; Shah ND; Abouassally R; Sun M; Kim SP
    JAMA Intern Med; 2015 May; 175(5):792-9. PubMed ID: 25751604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer.
    Tyson MD; Graves AJ; O'Neil B; Barocas DA; Chang SS; Penson DF; Resnick MJ
    JAMA Surg; 2017 Jan; 152(1):27-34. PubMed ID: 27653425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer.
    Loeb S; Berglund A; Stattin P
    J Urol; 2013 Nov; 190(5):1742-9. PubMed ID: 23727309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: a qualitative analysis of community and academic urologists.
    Ellis SD; Hwang S; Morrow E; Kimminau KS; Goonan K; Petty L; Ellerbeck E; Thrasher JB
    BMC Cancer; 2021 May; 21(1):649. PubMed ID: 34058998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Impact of a Genomic Classifier of Metastatic Risk on Postprostatectomy Treatment Recommendations by Radiation Oncologists and Urologists.
    Taneja SS
    J Urol; 2016 May; 195(5):1472. PubMed ID: 27186730
    [No Abstract]   [Full Text] [Related]  

  • 15. Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey.
    Ariane MM; Ploussard G; Rebillard X; Malavaud B; Rischmann P; Hennequin C; Mongiat-Artus P
    World J Urol; 2015 Nov; 33(11):1741-7. PubMed ID: 25822706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.
    Womble PR; Montie JE; Ye Z; Linsell SM; Lane BR; Miller DC;
    Eur Urol; 2015 Jan; 67(1):44-50. PubMed ID: 25159890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
    van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
    BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer.
    Kim SP; Gross CP; Nguyen PL; Smaldone MC; Thompson RH; Shah ND; Kutikov A; Han LC; Karnes RJ; Ziegenfuss JY; Tilburt JC
    Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):163-9. PubMed ID: 24566445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.
    Albertsen PC; Albertsen PC
    J Urol; 2001 Feb; 165(2):731-2. PubMed ID: 11233050
    [No Abstract]   [Full Text] [Related]  

  • 20. Words of wisdom. Re: Medium-term outcomes of active surveillance for localized prostate cancer.
    Mir MC; Stephenson AJ
    Eur Urol; 2013 Dec; 64(6):1013-4. PubMed ID: 24209447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.